The insulin-like signaling pathway maintains a relatively short wild-type lifespan in Caenorhabditis elegans by phosphorylating and inactivating DAF-16, the ortholog of the FOXO transcription factors of mammalian cells. DAF-16 is phosphorylated by the AKT kinases, preventing its nuclear translocation. Calcineurin (PP2B phosphatase) also limits the lifespan of C. elegans, but the mechanism through which it does so is unknown. Herein, we show that TAX-6•CNB-1 and UNC-43, the C. elegans Calcineurin and Ca2+/calmodulin-dependent kinase type II (CAMKII) orthologs, respectively, also regulate lifespan through DAF-16. Moreover, UNC-43 regulates DAF-16 in response to various stress conditions, including starvation, heat or oxidative stress, and cooperatively contributes to lifespan regulation by insulin signaling. However, unlike insulin signaling, UNC-43 phosphorylates and activates DAF-16, thus promoting its nuclear localization. The phosphorylation of DAF-16 at S286 by UNC-43 is removed by TAX-6•CNB-1, leading to DAF-16 inactivation. Mammalian FOXO3 is also regulated by CAMKIIA and Calcineurin.https://doi.org/10.7554/eLife.00518.001
Although aging might seem to be a passive process—resulting simply from wear and tear over a lifetime—it can actually be accelerated or slowed down by genetic mutations. This phenomenon has been most thoroughly studied in the nematode worm, Caenorhabditis elegans. Normally, this worm lives for just two or three weeks, but genetic mutations that reduce the activity of certain enzymes in a series of biochemical reactions known as the insulin/IGF-1 signalling pathway can extend its lifespan by up to a factor of ten, and similar effects have been seen in flies and mice. Lifespans can also be increased by blocking other signalling pathways or restricting the intake of calories.
This increase in lifespan associated with the insulin/IGF-1 signalling pathway is known to involve a protein called DAF-16 and two kinases called AKT-1 and AKT-2. Under normal conditions the AKT kinases add several phosphate groups to the DAF-16, which prevents it from travelling to the nucleus of the cell. However, when genetic techniques are used to block the insulin/IGF-1 signalling pathway, the AKT kinases are unable to add the phosphate groups; this leaves the DAF-16 free to enter the nucleus, where it activates a network of genes that promotes longevity.
In addition to kinases, the insulin/IGF-1 signalling pathway also involves enzymes called phosphatases that remove the phosphate groups from other proteins. In particular, a phosphatase called calcineurin is known to be involved in the regulation of lifespan, but the details of this process are not fully understood.
Now, Tao et al. have carried out a series of genetic and biochemical experiments to determine how phosphatases exert their influence on aging. The results show that calcineurin targets DAF-16, the same protein that is targeted by the AKT kinases. Moreover, another kinase also targets DAF-16 when the worm is exposed to heat, starvation or some other form of stress: this kinase, which is not involved in the insulin/IGF-1 signalling pathway, is called CAMKII.
Tao et al. show that these kinases act on DAF-16 in different ways: CAMKII activates it by adding the phosphate group at a specific site known as S286, whereas the AKT kinases deactivate DAF-16 because they add phosphate groups at different sites, thereby preventing it from entering the nucleus. Calcineurin neutralizes the effect of CAMKII by removing the phosphate group at S286 to deactivate the DAF-16.
In addition to shedding new light on the regulation of lifespan in C. elegans, the new results could improve our understanding of aging in humans, and also the development of diabetes and other age-related diseases, because the equivalent molecules in mammalian cells are regulated in similar ways.https://doi.org/10.7554/eLife.00518.002
Multiple signaling pathways, including insulin/IGF-1 signaling (IIS), germline signaling, mitochondrial signaling, and the signaling pathways induced by dietary restriction, regulate aging in C. elegans (Kenyon, 2005; Greer and Brunet, 2008). The best characterized is the IIS pathway, which includes the upstream insulin/IGF-1 receptor DAF-2 and the downstream FOXO transcription factor DAF-16. Signals from DAF-2 are transmitted through AGE-1 (phosphoinositide 3-kinase) and PDK-1 (phosphoinositol-dependent kinase-1) to AKT-1, AKT-2, and SGK-1, which phosphorylate DAF-16 and prevent it from translocating to the nucleus to activate a pro-longevity gene network. Reduction-of-function mutations of the kinase genes in the IIS pathway, from daf-2 to akt-1, akt-2, and sgk-1, all extend lifespan in a daf-16-dependent manner (Kenyon et al., 1993; Morris et al., 1996; Kimura et al., 1997; Hertweck et al., 2004). Lifespan extension by reduced IIS is also observed in other species, including flies and mice, indicating that the pathway is conserved evolutionarily (Kenyon, 2005; Greer and Brunet, 2008).
Compared with the kinases in the C. elegans IIS pathway, little is known about the protein phosphatases that neutralize the effects of the kinases. The only known example is PPTR-1, a B56 regulatory subunit of PP2A, which directs PP2A to dephosphorylate AKT-1 at T350, thereby inactivating the kinase (Padmanabhan et al., 2009). DAF-18, the C. elegans PTEN, is a phosphatidylinositol 3,4,5-trisphosphate (PIP3) 3-phosphatase (Ogg and Ruvkun, 1998). The phosphatase for DAF-2 has not been identified, nor the one that regulates DAF-16. Previously, loss-of-function (lf) mutants for tax-6 and cnb-1, which encode the catalytic and regulatory subunits of C. elegans Calcineurin, respectively, were found to live longer than wild-type (WT) worms (Dong et al., 2007). In mammalian systems, Calcineurin (PP2B) is a Ca2+/calmodulin-dependent serine/threonine protein phosphatase that has diverse functions and affects both T cell activation and heart development (Crabtree, 1999). In C. elegans, Calcineurin regulates body size, thermotaxis, muscle contraction, and lifespan (Bandyopadhyay et al., 2002; Kuhara et al., 2002; Lee et al., 2004; Dong et al., 2007). The longevity phenotype of tax-6(lf) is partially dependent on daf-16 (Dong et al., 2007). More recent studies have shown that C. elegans Calcineurin can regulate lifespan by suppressing autophagy (Dwivedi et al., 2009) or inactivating CRTC-1, a co-activator of CREB (Mair et al., 2011). However, direct targets of worm Calcineurin have not been identified.
In the current work, we addressed how worm Calcineurin TAX-6•CNB-1 regulates lifespan. We discovered that DAF-16 was phosphorylated and activated by UNC-43 at the serine 286 (S286) site. The phosphoryl group was removed by TAX-6•CNB-1. UNC-43 and TAX-6•CNB-1 therefore regulate C. elegans lifespan through the reversible phosphorylation of DAF-16. This regulatory mechanism has a different mode of action from the canonical IIS pathway because the phosphorylation activates, rather than represses, DAF-16. Activation of DAF-16 by UNC-43 occurs in response to different types of stress signals, such as heat, starvation, and oxidation. UNC-43 and TAX-6•CNB-1 can regulate DAF-16 independently of IIS, and the two signaling mechanisms appear to crosstalk, leading to coordinated action on DAF-16. We also show that the regulation of FOXO by CAMKII and Calcineurin is conserved in mammalian cells.
A genetic analysis has shown that a daf-16(null) allele partially suppresses the longevity of the tax-6(lf) mutant (Dong et al., 2007). This observation suggested that daf-16 is either a direct or indirect downstream target of C. elegans Calcineurin; alternatively, it acts independently. To sort through these possibilities, we immunoprecipitated the 3xFLAG::DAF-16 protein using an anti-FLAG antibody from the lysate of MQD82, a transgenic worm strain that expresses this fusion protein and TAX-6::GFP (Figure 1A, lane 1). TAX-6::GFP from this lysate was co-precipitated with the FLAG antibody (Figure 1A, lane 4), but no TAX-6::GFP was co-precipitated from the lysate of MQD2, a strain expressing only TAX-6::GFP (Figure 1A, lanes 2 and 5). From the mixed lysates of two other transgenic strains, one expressing 3xFLAG::DAF-16 and the other expressing GFP, the GFP protein also failed to be precipitated by the FLAG antibody (Figure 1A, lanes 3 and 6). This result suggested that TAX-6 and DAF-16 interacted with each other in vivo. To determine whether the interaction was direct, we individually purified the recombinant His-tagged DAF-16 and C. elegans Calcineurin in the form of TAX-6•GST-CNB-1 and then mixed them together before pulling down DAF-16 with nickel beads. Indeed, TAX-6•GST-CNB-1 was pulled down successfully using His-tagged DAF-16 (Figure 1B). Further analysis suggested that the C-terminal region of DAF-16 mediates the interaction with Calcineurin (Figure 1C). Together, these results raised the interesting possibility that Calcineurin might directly regulate DAF-16 in C. elegans.
In WT animals, DAF-16 is phosphorylated by AKT and diffusely distributed throughout the cell, whereas in long-lived IIS mutants, transcriptionally active DAF-16 accumulates in the nucleus (Henderson and Johnson, 2001; Lin et al., 2001). To determine whether DAF-16 translocates to the nucleus in long-lived Calcineurin mutants, we expressed DAF-16::6xHis::GFP using a daf-16 promoter in the tax-6(ok2065) background. The functionality of this transgene was verified in daf-2(e1370ts);daf-16(mu86) animals; the double mutant expressing this transgene displayed the dauer formation-constitutive (Daf-c) and longevity phenotypes of the daf-2(e1370ts) single mutant (not shown). DAF-16::6xHis::GFP clearly accumulated in the nuclei of different types of cells in tax-6(ok2065) (Figure 1D), similar to daf-2(lf) and akt-1;akt-2(RNAi) mutants (Henderson and Johnson, 2001).
The above results strongly suggested that Calcineurin directly inhibited DAF-16, presumably by dephosphorylating it. This result is in contrast to the transmission of IIS signaling to DAF-16, during which phosphorylation of DAF-16 by AKT inhibits its nuclear accumulation. Thus, AKT and Calcineurin regulate the phosphorylation of different sites on DAF-16; otherwise, tax-6(lf) would have a lifespan phenotype opposite to that of akt-1;akt-2(lf) or daf-2(lf). In contrast, they all live longer than WT worms. Therefore, Calcineurin must counteract a different kinase that activates DAF-16.
We reasoned that nuclear accumulation of DAF-16 in the tax-6(null) background should be dependent on a kinase that initiated the phosphorylation and nuclear translocation of DAF-16. Inactivation of this kinase should abolish the nuclear accumulation of DAF-16::GFP in tax-6(null) animals. We thus conducted an RNAi screen of kinase genes using the DAF-16::6xHis::GFP reporter in tax-6(ok2065) worms, in which the GFP signal accumulates in the nucleus (Figure 2—figure supplement 1). We obtained from the Ahringer library a strong suppressor of nuclear DAF-16::GFP in an RNAi clone that targets unc-43 (Figure 2—figure supplement 2). The suppression was confirmed by an independent, homemade unc-43 RNAi construct (Figure 2A). The unc-43 gene encodes the only Ca2+/calmodulin-dependent serine/threonine protein kinase, type II (CAMKII), in C. elegans (Reiner et al., 1999). UNC-43 and Calcineurin have opposing functions in locomotion and egg laying, two behavioral phenotypes that are regulated by G protein signaling (Reiner et al., 1999; Bandyopadhyay et al., 2002). However, they also have non-overlapping functions because unc-43(lf);cnb-1(null) double mutant animals arrest at the L1 larval stage, whereas both single mutants are viable (Reiner et al., 1999; Bandyopadhyay et al., 2002).
To verify that UNC-43 and Calcineurin regulate DAF-16 antagonistically, we examined whether unc-43(RNAi) could suppress the longevity of Calcineurin loss-of-function mutants and whether unc-43(gf) had the same phenotype as tax-6(lf). Although RNAi knockdown of tax-6 during adulthood increased the lifespan of WT worms (Figure 2B, Figure 2—source data 1A), it failed to increase the lifespan of unc-43(null) animals (Figure 2C, Figure 2—source data 1A). This observation is consistent with the hypothesis that Calcineurin removes the activating phosphorylation on DAF-16 caused by UNC-43. We then examined n498, an unc-43 gain-of-function (gf) allele harboring a missense mutation that results in constitutive activation of the kinase (Park and Horvitz, 1986; Reiner et al., 1999). This unc-43(gf) allele caused DAF-16::6xHis::GFP to accumulate in the nucleus (Figure 2D), phenocopying tax-6(lf) (Figure 2A). Furthermore, the unc-43(n498) mutant lived 80% longer than the WT animals, and this lifespan extension was largely dependent on daf-16 (Figure 2E, Figure 2—source data 1B).
Consistent with UNC-43 activating DAF-16 to prolong lifespan and TAX-6•CNB-1 antagonizing such action, we found that the unc-43(gf);cnb-1(lf) double mutant lived even longer than either single mutant (Figure 2F, Figure 2—source data 1C).
Previous studies have shown that UNC-43 activates NSY-1 and SEK-1, two kinases within the MAP kinase pathway, to repress str-2 expression (Sagasti et al., 2001). To determine whether UNC-43 activated DAF-16 through NSY-1 (MAPKKK) and SEK-1 (MAPKK), we treated unc-43(n498) worms expressing the DAF-16::6xHis::GFP transgene with nsy-1 and sek-1 RNAi and found that neither gene affected DAF-16 nuclear accumulation induced by unc-43(gf) (Figure 3A). RNAi against pmk-2, which encodes a p38 MAP kinase (Kim et al., 2002; Tanaka-Hino et al., 2002), also had no effect (Figure 3A). sek-1 regulates DAF-16 localization in response to oxidative stress (Kondo et al., 2005). To ascertain the role of sek-1 in the nuclear accumulation of DAF-16 induced by unc-43(gf), we crossed the DAF-16::6xHis::GFP animal to a unc-43(gf);sek-1(null) double mutant. Similar to the RNAi treatment, the km4(null) allele of sek-1 failed to prevent DAF-16 nuclear localization in unc-43(gf) animals (Figure 3B). Moreover, the unc-43(gf);sek-1(null) double mutant did not live a shorter life than unc-43(gf) animal (Figure 3C, Figure 3—source data 1). Thus, we conclude that UNC-43 does not activate DAF-16 through the NSY-1/SEK-1 MAP kinase pathway.
To test whether DAF-16 is a direct substrate of UNC-43, we constructed transgenic strains that co-expressed 3xHA::UNC-43 and 3xFLAG::DAF-16 (MQD522) or expressed either 3xHA::UNC-43 (MQD530) or 3xFLAG::DAF-16 (MQD89) under the control of own promoter. The 3xHA::UNC-43 protein was found in the immunoprecipitate of 3xFLAG::DAF-16 and vice versa (Figure 4A–B), suggesting that UNC-43 and DAF-16 can form a complex in vivo. Using purified recombinant proteins, we found that GST-UNC-43 but not GST or calmodulin (CAM), was pulled down by nickel beads via 6xHis-DAF-16 (Figure 4C).
We then asked whether UNC-43 phosphorylates DAF-16. We performed an in vitro kinase assay using purified GST-UNC-43, Ca2+/CAM, and 6xHis-DAF-16 in the presence of [32P]-γ-ATP. GST-UNC-43 readily phosphorylated DAF-16 in vitro (Figure 4D). To map the phosphorylation site(s), truncated DAF-16 proteins were used as kinase substrates. UNC-43 phosphorylated the DAF-16 N-F fragment (1–267 aa) but not the N-terminal fragment (1–142 aa) (Figure 4E), suggesting that the phosphorylation site(s) resides in the region containing the forkhead domain (143–267 aa) and/or the C-terminal region (268–508 aa). A mass spectrometry (MS) analysis of the full-length 6xHis-DAF-16 after the in vitro kinase reaction identified two DAF-16 residues T240 and S286 that were phosphorylated by UNC-43 (Figure 5—figure supplement 1, Figure 5A). T240 and S286 are among the predicted CAMKII sites (RXXS/T or S/TXD). To confirm the MS result, we made two antibodies, one that specifically recognized phospho-T240 and one that specifically recognized phospho-S286. Using these antibodies, we verified that DAF-16 was indeed phosphorylated by UNC-43 at T240 and S286 in vitro (Figure 5B–C).
To confirm whether DAF-16 is phosphorylated in vivo at both sites in an UNC-43-dependent manner, we immunoprecipitated phospho-DAF-16::6xHis::GFP from daf-16(null);unc-43(gf) or daf-16(null) mutants using the phospho-DAF-16-specific antibodies and followed with anti-GFP immunoblotting. Interestingly, there was a marked increase of DAF-16 S286 phosphorylation, but not T240 phosphorylation, in the unc-43(gf) mutant (Figure 5D–E). S286A and T240A mutations completely abolished phosphorylation on the respective sites (Figure 5C–E). We thus concluded that UNC-43 phosphorylates DAF-16 specifically on S286. Apparently, T240 phosphorylation by UNC-43 does not occur in vivo under the tested condition.
To test whether TAX-6 dephosphorylates DAF-16 at S286, we phosphorylated recombinant DAF-16 in vitro with UNC-43 and then incubated it with purified TAX-6•GST-CNB-1. As shown in Figure 5F, phosphorylation of DAF-16 at S286 was dramatically reduced by TAX-6•GST-CNB-1, while phosphorylation of T240 remained unchanged.
To validate the role of S286 in UNC-43- and TAX-6-regulated DAF-16 localization and longevity, we introduced the DAF-16(S286A)::6xHis::GFP transgene into daf-16(mu86);unc-43(gf) and daf-16(mu86);tax-6(lf) mutants. While DAF-16::6xHis::GFP accumulated in the nuclei of tax-6(lf) and unc-43(gf) mutants, DAF-16(S286A)::6xHis::GFP distributed diffusely throughout the cell in the same mutant backgrounds (Figure 6A–B), and the pattern resembled that of DAF-16::6xHis::GFP in WT worms (Figure 1D). In C. elegans whose WT copy of DAF-16 was replaced by DAF-16(S286A), the lifespan extension by either unc-43(gf) or tax-6(lf) was greatly suppressed (Figure 6C–D, Figure 6—source data 1A,B). Thus, the S286 residue is required for DAF-16-dependent effects of unc-43(gf) and tax-6(lf), verifying that S286 is the regulatory site. In comparison, the constitutive nuclear localization phenotype of DAF-16(T240A) contradicts with the idea that UNC-43 phosphorylates T240 to promote DAF-16 nuclear accumulation (Figure 6—figure supplement 1). Rather, it corroborates the observation that UNC-43 does not phosphorylate T240 in vivo (Figure 5E).
To mimic phosphorylation by UNC-43, we mutated DAF-16 S286 to aspartic acid. When expressed in daf-16(mu86) animals, the DAF-16(S286D)::6xHis::GFP protein accumulated in the nucleus, whereas the WT DAF-16::6xHis::GFP protein was cytoplasmic, as expected (Figure 6E). Moreover, the phosphomimetic of DAF-16, but not the WT version, significantly increased the C. elegans lifespan in daf-16(null) animals (Figure 6F, Figure 6—source data 1C). The effect was not due to higher protein amounts of DAF-16(S286D) because DAF-16(S286D)::6xHis::GFP and DAF-16::6xHis::GFP were expressed at similar levels in these transgenic animals (Figure 6E, Figure 6—figure supplement 2).
Taken together, the S286D mutation mimicked the effect of unc-43(gf) and tax-6(lf) on DAF-16, whereas the S286A mutation of DAF-16 blocked the effects of unc-43(gf) and tax-6(lf). Thus, phosphorylation of S286 is critical for CAMKII and Calcineurin to regulate DAF-16 localization and longevity.
S286 is different from the known AKT phosphorylation sites (T54, S238, T240, and S312 for DAF-16b) of DAF-16 (Lin et al., 2001). Therefore, UNC-43 and TAX-6•CNB-1 most likely respond to conditions that are distinct from the conditions sensed by AKT in the IIS pathway. In addition to mutations that reduce insulin signaling, various stress conditions, including thermal stress, oxidative stress, and starvation, can trigger translocation of DAF-16 to the nucleus (Henderson and Johnson, 2001; Lin et al., 2001). Among the DAF-16 target genes are a wide range of stress response genes, including small heat shock proteins, a superoxide dismutase, catalases, and glutathione S-transferases (Murphy et al., 2003; Dong et al., 2007). Transcriptional activation of these target genes by nuclear DAF-16 helps the organism cope with stress, and daf-16 mutant worms survive stressful conditions less well than WT worms (Wolff et al., 2006).
To test whether UNC-43 is required for transmitting stress signals to DAF-16, we crossed DAF-16::6xHis::GFP into unc-43(null) and compared these animals to WT animals carrying the same transgene. At 20°C, DAF-16::6xHis::GFP displayed a cytoplasmic pattern in either WT or unc-43(null) animals. When these worms were transferred to 28°C, DAF-16::6xHis::GFP accumulated in the nucleus in WT worms but remained cytoplasmic in unc-43(null) animals (Figure 6G). Similarly, starvation and paraquat, a chemical that generates reactive oxygen species (ROS) inside the cells, caused DAF-16 to translocate to the nucleus in WT but not unc-43(null) worms (Figure 6G). The results demonstrated that unc-43 is required for nuclear accumulation of DAF-16 in response to different types of stress.
The site of DAF-16 that is phosphorylated by CAMKII is different from the site that is phosphorylated by AKT. Moreover, phosphorylation by AKT and CAMKII has opposite effects on DAF-16 activity (Figures 5 and 6 and Lin et al., 2001). Thus, the IIS pathway (DAF-2) and the CAMKII pathway might work in parallel. In agreement with this hypothesis, reduced IIS and increased phosphorylation of DAF-16 S286, either by unc-43(gf) or tax-6(lf), displayed an additive effect on lifespan (Figure 7A–B, Figure 7—source data 1A). These two pathways, however, also seem to crosstalk. First, an unc-43 null allele shortened the daf-2 lifespan by 31% (Figure 7C, Figure 7—source data 1B), indicating that unc-43 is required for full lifespan extension by daf-2(e1370). This result suggests that part of the signaling from DAF-2 is mediated by UNC-43. However, phosphorylation of DAF-16 S286 seems nonessential for the longevity of daf-2 animals (Figure 7—figure supplement 1, Figure 7—source data 1C), suggesting that an additional UNC-43 target(s) is involved in DAF-2 signaling. Second, in the constitutively active unc-43(gf) mutant, which has increased phosphorylation on DAF-16 S286 (Figure 5D), phosphorylation by AKT on T240 is greatly reduced (Figure 5E). Therefore, in long-lived unc-43(gf) animals, phosphorylation on these two residues appears to be coordinated, but it is unclear how this coordination occurs. The AKT kinase activity may be reduced in unc-43(gf), or phospho-S286 DAF-16 may be a poor substrate for AKT. In either case, dampened phosphorylation on the AKT site may be expected to prevent DAF-16 from forming a complex with the 14-3-3 protein, which has been shown to bind to and sequester AKT-phosphorylated FOXO (DAF-16 or mammalian FOXO3) in the cytoplasm (Brunet et al., 1999; Berdichevsky et al., 2006; Li et al., 2007). Consistently, we found that unc-43(gf) reduced the amount of DAF-16-associated 14-3-3 without affecting the total amount of 14-3-3 (Figure 7—figure supplement 2). It remains to be seen whether S286 phosphorylation directly or indirectly promotes DAF-16 nuclear accumulation.
While IIS and CAMKII/Calcineurin signaling act largely in parallel with each other, it is unclear what would happen if one pathway was in a state to inhibit DAF-16 while the other pathway was in a state that would activate it. To genetically mimic this scenario, we combined daf-2 RNAi with either unc-43(null) or tax-6(jh107), a constitutively active tax-6(gf) allele in which the autoinhibitory domain was deleted (Lee et al., 2004). DAF-16::GFP was cytoplasmic in unc-43(null) or tax-6(gf), but nuclear DAF-16::GFP was clearly visible above the cytoplasmic background in daf-2(RNAi), daf-2(RNAi);unc-43(null), or daf-2(RNAi);tax-6(gf) mutants (Figure 8A). We also combined daf-18 RNAi, which enhances IIS to inhibit DAF-16 (Ogg and Ruvkun, 1998), with unc-43(gf) or tax-6(lf), which activates DAF-16. In both cases, the nuclear accumulation induced by unc-43(gf) or tax-6(lf) was greatly diminished by daf-18 RNAi (Figure 8B). Therefore, under conditions in which there is a conflict between IIS and CAMKII/Calcineurin signaling toward DAF-16, the insulin signaling pathway appears to dominate.
Based on the experimental evidence above, we propose a model (Figure 8C) in which DAF-16 integrates hormonal signals and stress signals transmitted by the IIS pathway (from DAF-2 to AKT) and CAMKII (UNC-43), respectively. CAMKII and the counterbalancing phosphatase Calcineurin (TAX-6•CNB-1) act in parallel and coordinately with the IIS pathway to regulate DAF-16 activity.
Sequence analysis of FOXO proteins revealed that DAF-16 S286, the CAMKII phosphorylation site, is widely conserved in nematode species, zebra fish, frogs, mice, and humans (Figure 9A). It is equivalent to S298 of mouse FOXO3 (mFOXO3) and S299 of human FOXO3 (hFOXO3) (Figure 9A), and may be the equivalent of S303 of human FOXO1 or S300 of mouse FOXO1 (not shown). Such conservation suggests that mammalian FOXO proteins are likely regulated by CAMKII and Calcineurin.
To determine if this is true, we first expressed a FLAG-tagged mouse FOXO3 together with a GFP-tagged mouse CAMKII alpha (CAMKIIA) or beta (CAMKIIB) isoform, or a Myc-tagged human Calcineurin A (CnA) in HEK293T cells, and found that CAMKII and CnA both interact with FOXO3 (Figure 9B–C). Next, we asked whether CAMKII phosphorylates FOXO3 in vitro. Purified GST fusion proteins containing five non-overlapping fragments of FOXO3 (Lehtinen et al., 2006) were incubated with an active recombinant human CAMKIIA. CAMKIIA robustly phosphorylated the P2 and P3 fragments but not the others (Figure 9D), placing the phosphorylation sites within aa 154–409. Mass spectrometry and mutagenesis studies of the full-length mFOXO3 or the P2 and P3 fragments from the in vitro kinase assay mapped the CAMKIIA phosphorylation sites to S252, S279, and S298 (not shown). The same sites were also identified from FLAG-mFOXO3 co-expressed with CAMKIIA in HEK293T cells (Figure 9E, Figure 9—figure supplement 1). However, only mFOXO3 S298, which corresponds to DAF-16 S286, had a significant increase in phosphorylation when cells were co-transfected with CAMKIIA (Figure 9F). This shows that S298 is the principle CAMKIIA phosphorylation site in vivo. S252 in mouse FOXO3 or S253 in human FOXO3, the counterpart of DAF-16 T240 (Figure 9A), is a highly conserved AKT phosphorylation site (Brunet et al., 1999). Using a specific antibody, we found that neither CAMKIIA nor Calcineurin regulated phosphorylation of endogenous human FOXO3 at S253 in HEK293T cells (Figure 9—figure supplement 2). Moreover, Calcineurin can reduce the phosphorylation of the FOXO3-P3 fragment (containing S298) by CAMKIIA, but not that of the P2 fragment (containing S252) (Figure 9—figure supplement 3). Taken together, these results demonstrate that mammalian CAMKII and Calcineurin regulate phosphorylation of FOXO3 at the same conserved site as in C. elegans (S298 in mouse FOXO3 and S286 in DAF-16).
A recent study by Ozcan et al. shows that four non-AKT phosphorylation sites are involved in the activation of murine FOXO1 by CAMKIIγ, likely through the p38 MAP kinase, in glucagon-stimulated hepatocytes (Ozcan et al., 2012). Serine 300 of mouse FOXO1, the equivalent of S298 of mouse FOXO3, is not among them (S246, S295, S467, and S475). To find out whether the CAMKIIA isoform phosphorylates FOXO1 in the same way as it does FOXO3, we expressed a FLAG-tagged human FOXO1 in HEK293T cells co-transfected or not with CAMKIIA. Mass spectrometry analysis identified three CAMKIIA-regulated phosphorylation sites equivalent to mouse FOXO1 S295, S467, and S475 (not shown). This agrees with the findings by Ozcan et al. and suggests that CAMKII directly phosphorylates FOXO3 but not FOXO1 in mammals.
Lastly, we determined whether CAMKII and Calcineurin regulate the transcriptional activity of FOXO3. Mammalian CAMKII can be activated by autophosphorylation at threonine 286 (Mukherji et al., 1994; Rich and Schulman, 1998). Mutation of this residue to A or D results in a kinase dead or constitutively active form of CAMKII, respectively (Fong et al., 1989). Using a luciferase reporter assay, we found that the transcriptional activity of FOXO3 was indeed stimulated by CAMKIIA in a way that required S298 of FOXO3 (Figure 10A) and T286 of CAMKIIA (Figure 10B), and further enhanced by the constitutively active CAMKIIA mutant (Figure 10C). Consistently, expression of Calcineurin significantly inhibited the transcriptional activity of FOXO3 (Figure 10D). From these results, we conclude that CAMKIIA and Calcineurin oppose each other in regulating the transcriptional activity of mouse FOXO3 through phosphorylation or dephosphorylation at S298. This mechanism is conserved from C. elegans to mammals.
Our data suggest that CAMKII (UNC-43) and Calcineurin (TAX-6•CNB-1), by phosphorylating or de-phosphorylating serine 286 of DAF-16, extend or shorten the lifespan of C. elegans. The direct, antagonistic nature of these two enzymes also raised an interesting possibility that, with their opposing effects on DAF-16 and a common activating signal (Ca2+/CAM), UNC-43 and TAX-6•CNB-1 would constitutively negate each other and have essentially no control of DAF-16. However, this outcome most likely does not occur because of the difference in the spatial distribution and temporal activation profiles of the two enzymes. TAX-6 and CNB-1, similar to DAF-16, are expressed in most cells in C. elegans (Ogg et al., 1997; Bandyopadhyay et al., 2002; Kuhara et al., 2002; Dong et al., 2007). In contrast, unc-43 promoter-driven GFP was only detected in neurons and the intestine (Hunt-Newbury et al., 2007). We also detected UNC-43 primarily in the nervous system (not shown).
At the subcellular level, the TAX-6::GFP fusion protein is distributed diffusely throughout the cytoplasm and inside the nucleus (Kuhara et al., 2002; Dong et al., 2007). In contrast, the CFP::UNC-43 fusion protein is concentrated on perinuclear structures and clusters in neurites (Umemura et al., 2005). Temporally, Ca2+-activated CAMKII phosphorylates another molecule of CAMKII at T286 to convert it to a Ca2+/CAM-independent kinase, prolonging the kinase activity after the initial activation (Erickson et al., 2011). CAMKII can also be activated by ROS at low Ca2+ concentrations (Erickson et al., 2011). In mammalian cells, inhibition of Calcineurin by cytoplasmic CAMKII and inhibition of CAMKII by Calcineurin have both been reported (MacDonnell et al., 2009; Kubokawa et al., 2011), suggesting that the balance is intricately maintained. Therefore, in the case of the simultaneous activation of CAMKII and Calcineurin by Ca2+/CAM, either the kinase or the phosphatase could dominate the regulation of DAF-16 either locally (e.g., cytoplasm vs nucleus) or for certain time windows. This balance likely fine-tunes the DAF-16 activity in response to a changing environment.
It is likely that UNC-43/Calcineurin is responsible for activating DAF-16 when worms experience a variety of stress signals, including heat stress, oxidative stress, or prolonged starvation (Figure 6G). Food deprivation acts through UNC-43 to suppress spontaneous sex-muscle contraction in C. elegans males (LeBoeuf et al., 2007). Reported in HEK293T cells, human FOXO3 is phosphorylated at non-AKT sites under stress conditions such as heat shock or H2O2 treatment (Brunet et al., 2004). ROS-induced oxidation of two methionine residues activates CAMKII, and this activation can occur under conditions of low Ca2+ (Erickson et al., 2011). Thus, CAMKII is perfectly equipped to transmit ROS signaling and calcium signaling, and phosphorylation of FOXO3 by CAMKII may play a highly conserved role in the stress response, from worms to humans.
To date, DAF-16 is the only biochemically and genetically proven substrate of TAX-6•CNB-1, but it is not the only substrate involved in lifespan regulation by Calcineurin. Inactivation of CRTC-1, a coactivator of CREB, contributes to the longevity of tax-6(lf) animals (Mair et al., 2011). Hence, CRTC-1 is an excellent candidate, although it has not been shown that TAX-6•CNB-1 directly dephosphorylates CRTC-1. There may be additional substrates. Regardless, the discoveries made thus far jointly provide a good explanation for the large but incomplete suppression of tax-6(lf) longevity by daf-16(null) (Dong et al., 2007).
Post-transplant new-onset diabetes mellitus (NODM) is a frequent and serious complication for organ transplant patients. One of the NODM risk factors is the use of Calcineurin inhibitors, such as cyclosporin A and FK506, which suppress immune-rejection of donor organs (Heisel et al., 2004). In light of this work, we propose that sustained activation of FOXO3 resulting from chronic inhibition of Calcineurin may cause NODM in transplant patients. Given the conservation and broad tissue distribution of CAMKII, Calcineurin, and FOXO3, the regulatory mechanism uncovered in this study likely plays a role in many physiological functions.
All strains were cultured at 20°C following standard protocols unless otherwise indicated (Brenner, 1974). Double mutants were made using standard genetic methods, and the genotypes were confirmed using PCR or PCR followed by sequencing. The strains and oligos used in the study are listed in Supplementary file 1A,B, respectively.
The following antibodies were purchased: Mouse anti-Actin (Sigma-Aldrich, St Louis, MO), Mouse anti-tubulin (Sigma-Aldrich), mouse anti-CAM (Millipore, Billerica, MA), mouse anti-FLAG (Sigma-Aldrich), anti-FLAG M2 Affinity Gel (Sigma-Aldrich), rabbit anti-GFP (Abmart, Shanghai, China), mouse anti-GFP (Roche, Basel, Switzerland), rabbit anti-GFP (Invitrogen, Carlsbad, CA), rabbit anti-GST (GeneSci, Beijing, China), monoclonal anti-HA agarose (Sigma-Aldrich), rabbit anti-mFOXO3(phospho-S252)/hFOXO3(phospho-S253) (Cell Signaling, Danvers, MA), Mouse anti-Myc (Santa Cruz Biotechnology, Dallas, TX), goat anti-mouse IgG HRP (Jackson Immuno Research, West Grove, PA), and goat anti-rabbit IgG HRP (BaiHuiZhongYuan, Beijing, China). Rabbit α-HA and monoclonal mouse α-DAF-16 antibodies were made at the antibody center of the NIBS, Beijing. A single-chain anti-GFP antibody was produced as described before (Kubala et al., 2010) and cross-linked to NHS-activated Sepharose 4 Fast Flow beads (GE Healthcare, Piscataway Township, NJ). We called this GBP beads. To produce the DAF-16 antibody, full-length DAF-16b was cloned into the His-tag vector pET-28a, expressed in Escherichia coli BL21, and purified by Ni-NTA resin (Qiagen). Rabbit α-DAF-16b(pT240) and α-DAF-16b(pS286) antibodies were custom made and affinity purified at Abmart (Shanghai, China) using the synthetic DAF-16 phospho-peptides ‘RERSN(pT)IETTT-C’ and ‘SIQTI(pS)HDLYD-C,’ respectively. A Rabbit polyclonal anti-human 14-3-3 antibody that recognizes both C. elegans 14-3-3 proteins was a gift from Dr Yamei Wang (Xiamen University, China).
The daf-16 constructs were subcloned and further modified from a Pdaf-16::daf-16b::gfp construct described previously (the daf-16b isoform used to be called daf-16a2) (Henderson and Johnson, 2001). The GST-CNB-1 and TAX-6 bacterial expression constructs were modified from the GST-CNB-1 and GST-TAX-6 plasmids reported before (Bandyopadhyay et al., 2002). The unc-43 expression constructs were made from unc-43 cDNAs that were amplified from a C. elegans cDNA library. The constructs expressing full-length or truncated mouse FOXO3 have been described (Lehtinen et al., 2006), and the FOXO3-P2-S252A mutant was made by site-directed mutagenesis. The CAMKIIA and CAMKIIB expression constructs have described (Gaudillière et al., 2004). The Myc-CnA and Myc-CnB expression constructs under the CMV promoter were subcloned from ‘pET15b CnA CnB’ (Addgene). The FKRE-luciferase expression vector was kindly provided by Dr Azad Bonni (Harvard Medical School).
GST-CNB-1 and TAX-6 were co-expressed in E. coli BL21 and affinity purified using glutathione Sepharose (GE Healthcare) in PBS containing 0.5% NP-40 following standard protocols. GST-DAF-16(N) and GST-DAF-16(N-F) were purified in the same manner. Recombinant GST-UNC-43 was purified as described above but using a buffer containing 50 mM Tris-HCl, pH 7.6, 150 mM NaCl, 0.5% NP-40. Recombinant 6xHis-DAF-16 and 6xHis-DAF-16-6AM were expressed in BL21 and affinity purified using Ni-NTA agarose resin (Qiagen) in buffer containing 20 mM HEPES, pH 7.5, 150 mM NaCl, and 0.5% NP-40. His-tagged proteins were eluted off beads by adding 250 or 500 mM imidazole to the buffer after a 30 mM imidazole wash. Eluted proteins underwent buffer exchange and were concentrated using Centricon purifying units (Millipore) with 10-kDa (for TAX•GST-CNB-1) or 50-kDa (for other proteins) cutoffs to 0.5–1.0 mg/ml protein in storage buffer (20 mM HEPES, pH 7.5, 150 mM NaCl, 0.5% NP-40, 10% glycerol); the resulting solutions contained >1 mM glutathione or >5 mM imidazole. Bovine Calmodulin and human Calcineurin were purchased from Merck. Active human GST-CAMKIIA was ordered from Sigma. Recombinant mFOXO3 P1-P5 fragments were purified as described (Lehtinen et al., 2006).
Lifespan assays were carried out at 20°C unless otherwise indicated. To synchronize worms, twenty adult worms were allowed to lay eggs on NGM plates for 4 hr before being removed. After the progeny grew to the L4 stage, they were transferred to new plates (10 worms/plate). At least ten plates (100 worms) were used for the lifespan assay of each strain or RNAi treatment. Worms were transferred to fresh plates every 2 days until they ceased laying egg, after which worms were transferred to fresh plates every week. For lifespan assays that involved or would be compared with the unc-43(gf) mutant, 50 μg/ml FUDR was added to the plates to prevent its Egl (egg-laying defective) phenotype from interfering with lifespan measurement. In these experiments (Figure 2—source data 1B; Figure 2—source data 1C; Figure 3—source data 1; Figure 6—source data 1A; Figure 6—source data 1C; Figure 7—source data 1A), worms were transferred to fresh plates every 4 days until death. Live worms were scored every 2 days. Worms were considered dead if they failed to respond to gentle touches with a worm pick on the head and tail. Worms that had internally hatched larvae (‘bagged’) or ruptured vulvae (‘exploded’) or crawled off the agar surface were censored. SPSS (Statistical Package for the Social Sciences) software was used for the statistical analysis of the lifespan data, and the log-rank method was used to calculate p values.
RNAi assays were performed at 20°C using the feeding method as previously described (Kamath et al., 2003). Worms were fed RNAi bacteria from the time of hatching unless otherwise indicated. E. coli HT115(DE3) transformed with pAD12, an empty RNAi vector (Arantes-Oliveira et al., 2002), was used as a control. pTL13 is an RNAi construct targeting unc-43, which we generated by inserting a 332-bp cDNA fragment of unc-43 into the multiple cloning sites of pAD12. The other RNAi bacterial strains were obtained from the Ahringer RNAi library.
To examine the interaction between DAF-16 and TAX-6, 6xHis-DAF-16 was incubated with purified TAX-6•GST-CNB-1 complex in the presence of 2 μg CAM and 30 μl pre-washed Ni-NTA agarose resin (Qiagen) in binding buffer A (50 mM Tris, pH 8.0, 100 mM NaCl, 4 mM CaCl2, 2 mM MgCl2, 0.5% NP-40) at 4°C for 2 hr. The beads were then washed with washing buffer A (50 mM Tris, pH 8.0, 100 mM NaCl, 4 mM CaCl2, 2 mM MgCl2, 0.5% NP-40, 30 mM imidazole) and eluted with SDS loading buffer. Samples were resolved by SDS-PAGE and stained with Coomassie blue.
For DAF-16 and UNC-43 binding, 6xHis-DAF-16 was incubated with purified GST-UNC-43 and CAM in the presence of 30 μl pre-washed Ni-NTA agarose in binding buffer A without MgCl2. After binding, beads were washed with washing buffer A without MgCl2 and eluted with SDS loading buffer. The samples were resolved by replicate SDS-PAGE gels, one for Coomassie blue or silver staining, and the other for western blots with anti-GST, anti-DAF-16 or anti-CAM antibodies.
To map the TAX-6 binding site on DAF-16, 5 µg of GST or GST-tagged DAF-16 fragments were incubated with TAX-6::GFP-containing worm lysate (∼15 µg/µl proteins in 300 μl of 20 mM Tris, pH 8.0, 1% NP-40, 10% glycerol, 1x Protease Inhibitor Cocktail, EDTA free, Roche) and pre-washed glutathione beads at 4°C for 1 hr. The beads were washed three times and eluted with 1x SDS loading buffer.
Mixed-stage worms were cultured at 20°C on five 100-mm HG plates seeded with OP50, harvested, and washed with M9 buffer to yield 200–500 μl of packed worms. Then, 200 μl of packed worms was mixed with 200 μl of 2x lysis buffer A, B, or C (see below) and 800 μl of 0.5-mm diameter glass beads. The mixture was lysed using FastPrep-24 (MP Biomedicals) at 6.5 m/s, 20 s/pulse × 3 pulses with 5-min intervals on ice. Worm lysates were cleared by centrifugation at 13,000 rpm for 30 min. For anti-GFP and anti-FLAG IPs, the supernatant was incubated with GBP beads or anti-FLAG M2 beads for 1–2 hr. For the phospho-DAF-16 IP, the supernatant was incubated with 10 μl of the antibody specific for DAF-16(pT240) or DAF-16(pS298) and 30 μl of pre-washed protein A and protein G beads (mixed at 1:1) for 2 hr. After incubation with the lysates, the beads were washed 2–3 times with 1x lysis buffer, 5 min each time, and boiled in 2x SDS loading buffer for western blot analysis. All steps, from making the lysates to eluting the beads, were performed at 4°C.
1x lysis buffer A (for IP of DAF-16 and TAX-6): 20 mM Tris pH 8.0, 1% NP-40, 10% glycerol, 2 mM EDTA, 1x PIC (Protease Inhibitor Cocktail, EDTA free; Roche).
1x lysis buffer B (for IP of DAF-16 and UNC-43): 50 mM Tris, pH 8.0, 150 mM NaCl, 0.1% NP-40, 10% glycerol, 1x PIC, 1x PhosSTOP (Roche).
1x lysis buffer C (for IP of phospho-DAF-16): 50 mM Tris, pH 7.6, 150 mM NaCl, 0.1% SDS, 0.25% sodium deoxycholate, 1% NP-40, 2 mM EDTA, 1x PIC, 1x PhosSTOP.
Immunoprecipitation of FLAG-FOXO3 from HEK293T cells was performed as described (Xie et al., 2012).
2 μg of purified recombinant GST-UNC-43 (or 5 μg of purified active human GST-CAMKIIA) was incubated with 2 μg of CAM and 2–5 μg of purified 6xHis- or GST-tagged DAF-16 (or GST-FOXO3) in the kinase reaction buffer (50 mM PIPES, pH 7.0, 10 mM MgCl2, 4 mM CaCl2, 100 μM ATP, 1x PIC) in the presence or absence of [32P]-γ-ATP at 30°C for 15 min. Proteins were resolved by SDS PAGE and analyzed by autoradiography or WB with anti-DAF-16(pT240) or anti-DAF-16(pS286) antibodies.
The kinase reactions, performed as described above, were shifted to 60°C for 10 min to inactivate UNC-43 or CAMKIIA. Then the samples were incubated or not with 5 μg of TAX-6•GST-CNB-1 or Calcineurin in phosphatase buffer (50 mM Tris, pH 7.5, 100 mM NaCl, 6 mM MgCl2, 1 mM CaCl2, 1x PIC) in the presence of 2 μg CAM at 30°C for 30 min. The sample were resolved by SDS-PAGE and analyzed by autoradiography or by WB with antibodies specific for DAF-16(pT240), DAF-16(pS286), or mFOXO3(S252)/hFOXO3(S253).
Worms were cultured at 20°C on NGM plates from eggs laid within a 4-hr period and imaged at the L4 stage unless otherwise indicated. As soon as worms were removed from incubation, they were mounted on slides and imaged immediately. For the starvation challenge, approximately 100 L4 worms were placed on an empty plate and kept at 20°C for 20 hr before imaging. For the heat stress challenge, well-fed L4 worms on bacterial food were shifted to 28°C for 2 hr. Parallel samples were maintained at 20°C on food as controls. All GFP and DIC images were taken using a Zeiss Axio Imager M1 microscope at 400-fold magnification.
Coomassie blue-stained bands corresponding to in vitro phosphorylated DAF-16 or FOXO3 fragments, or FLAG-FOXO3 immunoprecipetated from 293T cells were destained and in-gel digested with trypsin. LC-MS/MS analyses of the resulting peptides were carried out on an LTQ-Orbitrap (ThermoFisher Scientific) or LTQ-Orbitrap Velos (ThermoFisher Scientific) as described before with slight modifications (Li et al., 2011). CID MS2 with neutral-loss triggered MS3 spectra were collected on LTQ-Orbitrap and HCD MS2 spectra were collected on LTQ-Orbitrap Velos. The MS2 or MS3 data were searched against the C. elegans protein database (for DAF-16) or the NCBI mouse protein database (for FOXO3). The pLabel software was used for spectral labeling (Yang et al., 2012).
HEK293T cells were maintained in DMEM medium supplemented with 10% fetal bovine serum (FBS) at 5% CO2. Transfection was carried out using Lipofectamine 2000 (Invitrogen), and the luciferase assays were carried out using the Dual-Luciferase assay kit (Promega).
The genetics of Caenorhabditis elegansGenetics 77:71–94.
Studies of the regulatory mechanism of Ca2+/calmodulin-dependent protein kinase II. Mutation of threonine 286 to alanine and aspartateJ Biol Chem 264:16759–16763.
Mutational analysis of secondary structure in the autoinhibitory and autophosphorylation domains of calmodulin kinase IIJ Biol Chem 269:20733–20738.
Mutations with dominant effects on the behavior and morphology of the nematode Caenorhabditis elegansGenetics 113:821–852.
Michael CzechReviewing Editor; University of Massachusetts Medical School, United States
eLife posts the editorial decision letter and author response on a selection of the published articles (subject to the approval of the authors). An edited version of the letter sent to the authors after peer review is shown, indicating the substantive concerns or comments; minor concerns are not usually shown. Reviewers have the opportunity to discuss the decision before the letter is sent (see review process). Similarly, the author response typically shows only responses to the major concerns raised by the reviewers.
Thank you for choosing to send your work entitled “CAMKII and Calcineurin Regulate the Lifespan of C. elegans through the FOXO Transcription Factor DAF-16” for consideration at eLife. Your article has been favorably evaluated by a Senior editor and 3 reviewers, one of whom is a member of our Board of Reviewing Editors.
The Reviewing editor and the other reviewers discussed their comments before we reached this decision, and the Reviewing editor has assembled the following comments to help you prepare a revised submission.
This paper is of substantial interest based on data revealing novel interactions between daf-16 in C. elegans and the orthologs of calcineurin and CamKII, powerful regulators in the mammalian immune system as well as metabolism. The data strongly support the authors’ hypothesis that daf-16 function is positively regulated by phosphorylation by the latter and negatively regulated by dephosphorylation of the former. Furthermore, stress responses appear to be mediated by this system in controlling life span in worms. However, recent data published by Ozcan et al (cited in the present paper but not discussed in sufficient detail) have revealed phosphorylation of FOXO by CamKII, nuclear translocation, and phospho sites that are distinct from AKT sites, so these findings are not completely novel. Nonetheless, this paper extends our information substantially and the impact would be even further strengthened with extension of the findings into a mammalian system. Major concerns are noted below:
1) All the data presented related to phosphorylation/dephosphorylation have been produced through the use of expressed tagged constructs. None of the conclusions are supported by isolations of the endogenous proteins. Although the bulk of the claims based on biochemical analysis are well supported by genetic studies, direct evidence of interactions and covalent modification of endogenous proteins would strengthen the paper. It is suggested, but not required, that the authors consider using antibodies against the endogenous proteins to confirm their data.
2) The T240 site does not appear to be regulated, although again these relevant data are from expressed tagged proteins. There are no genetic studies for this site provided, which would strengthen the concept that this site is not involved.
3) The conclusions of the paper would be substantively extended and the impact strengthened if the authors could provide evidence that this site of S286 of regulation of FOXO protein in mouse and human were operational. Good reagents are available for such studies, which would be easy to do in terms of both demonstrating phosphorylation/dephosphorylation as well as nuclear/cytoplasmic localization. In this regard, even though S286 is conserved in FOXO3, S303 in FOXO1, the equivalent of S299 in FOXO3, was not identified as a site whose phosphorylation was increased by CaMKIIg by Ozcan et al., and most of the reported sites were in Ser-Pro motifs, possibly phosphorylated as a result of p38 activation.
4) The sequence around DAF-16 S286(SIQTISHDLYD) is not that of a typical site for phosphorylation by CaMKII, which is a basophilic kinase, and is not predicted by Scansite to be a CaMKII site, even at low stringency, despite the authors’ in vitro evidence that CaMKII can directly phosphorylate S286. All the mapped CaMKII sites listed in PhosphoSitePlus that have a D at +2 also have an Arg or Lys at −3, which is not the case for S286. This deserves discussion and raises the issue of whether CaMKII directly phosphorylates DAF-16 in vivo.
5) Given the focus of the field to date on AKT regulation of FOXOs, the effect of the S286 phos status on the AKT site is very interesting. The submission goes some way to determining dominance between these two regulatory mechanisms (Figure 7), but it would benefit from going further in terms of the effects on aging. Does a S286A mutation or unc-43 null inhibit the longevity effects of DAF-2 or AKT loss of function: i.e., is phos of S286 necessary for lifespan extension by FOXO, rather than sufficient?
6) How does TAX-6/CNB-1 bind DAF-16 (i.e., what are the interaction domains in the two proteins?)?
7) How does phosphorylation of S286 promote nuclear import of DAF-16 (e.g., does it reduce 14-3-3 binding?)?https://doi.org/10.7554/eLife.00518.028
- Meng-Qiu Dong
- Zengqiang Yuan
- Zengqiang Yuan
- Meng-Qiu Dong
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
The authors wish to express sincere gratitude to Drs Thomas Johnson (University of Colorado, United States) for kindly providing the Pdaf-16::daf-16::gfp construct, Yamei Wang (Xiamen University, China) for providing the 14-3-3 antibody, and Joohong Ahnn (Hanyang University, Korea) for the GST fusion constructs of TAX-6 and CNB-1. Some strains were provided by the CGC, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440). We thank Dr Li-Lin Du for sequence analysis of the FOXO homologs, and Dr Xiaodong Wang for critical reading of the manuscript.
- Michael Czech, Reviewing Editor, University of Massachusetts Medical School, United States
- Received: January 7, 2013
- Accepted: May 24, 2013
- Version of Record published: June 25, 2013 (version 1)
© 2013, Tao et al.
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.